Product Information
KETOTIFEN 0.025% (0.035%) DROP is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $1.2940 per ML under NDC 76385010617. Its NADAC has been published 244 times since Feb 2, 2022.
FDA first approved this application on Jun 1, 2020.
Strength
.25 mg/mL
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
76385010617
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
KETOTIFEN FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204059FDA Approved
6/1/2020
On Market Since
10/15/2021
Pharmacological Classes
Price Statistics
The NADAC for KETOTIFEN 0.025% (0.035%) DROP has been published 244 times since Feb 2, 2022, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2940 per ML |
|---|---|
| All-time high | $1.5373 (Nov 16, 2022) |
| All-time low | $1.1312 (Apr 17, 2024) |
| 52-week high | $1.4207 |
| 52-week low | $1.2940 |
| Median price | $1.3415 |
| Average price | $1.3472 |
| Largest weekly change | -17.3% (Apr 17, 2024) |
| Weeks tracked | 244 |
| Tracking since | Feb 2, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the KETOTIFEN FUMARATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
KETOTIFEN FUMARATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOTIFEN 0.025% (0.035%) DROP?
The current National Average Drug Acquisition Cost (NADAC) for KETOTIFEN 0.025% (0.035%) DROP, manufactured by Unichem Pharmaceuticals (USA) Inc., is $1.2940 per ML (NDC 76385010617), effective Sep 30, 2026.
How has the price of KETOTIFEN 0.025% (0.035%) DROP changed over time?
Over the history we have for it, the NADAC for KETOTIFEN 0.025% (0.035%) DROP has declined 11.9%. It has been tracked across 244 weekly CMS publications since Feb 2, 2022.
What are the highest and lowest recorded NADAC prices for KETOTIFEN 0.025% (0.035%) DROP?
Since Feb 2, 2022, the NADAC for KETOTIFEN 0.025% (0.035%) DROP has ranged from a low of $1.1312 (Apr 17, 2024) to a high of $1.5373 (Nov 16, 2022), with a median of $1.3415 per ML.
Are there cheaper alternatives to KETOTIFEN 0.025% (0.035%) DROP?
No other NADAC-published product currently shares the active ingredient and strength of KETOTIFEN 0.025% (0.035%) DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KETOTIFEN 0.025% (0.035%) DROP?
KETOTIFEN 0.025% (0.035%) DROP (NDC 76385010617) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.